Events & Presentations

Date	Event Details
Jun 6, 2018 3:30 PM EDT	Jefferies 2018 Global Healthcare Conference Listen to webcast Supporting Materials: View Presentation 19.2 MB Location: New York, NY View Additional Information Chris Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will present a corporate overview
Jun 6, 2018 5:55 PM CEST	41st European Cystic Fibrosis Conference Supporting Materials: View Presentation 1 MB Location: Belgrade, Serbia View Additional Information Erik Bush, Ph.D., Arrowhead’s director of extra-hepatic targeting, will deliver an oral presentation titled,“Targeting aENaC with an epithelial RNAi trigger delivery platform for the treatment of cystic fibrosis”
May 21, 2018 9:15 AM PDT	American Thoracic Society (ATS) 2018 International Conference Supporting Materials: View Presentation 1 MB Location: San Diego
May 10, 2018 4:15 PM PDT	Vascular Discovery: From Genes to Medicine – Scientific Sessions 2018 Supporting Materials: View Presentation 8.5 MB Location: San Francisco
May 8, 2018 4:30 PM EDT	Arrowhead Fiscal 2018 Second Quarter Results Listen to webcast Supporting Materials: View Transcript 135.6 KB
Apr 25, 2018 4:00 PM EDT	World Orphan Drug Congress USA 2018 Supporting Materials: World Orphan Drug Congress 2018.pdf 6.3 MB
Apr 12 - Apr 14, 2018	The EASL International Liver Congress™ 2018 Supporting Materials: EASL 2018 ARC520-2001 OLE Poster 206.6 KB EASL 2018 ARO-HBV Talk 1 MB EASL 2018 ARO-AAT Talk 2.1 MB View Additional Information Oral Presentations: Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection Presentation Reference: PS-030 Session: Parallel session: Parallel session: HBV Cure: Pre-clinical studies Date and Time: April 12, 2018 at 5:15 p.m. CET Authors: Christine Wooddell, et al. ARO-AAT, a subcutaneous RNAi-based therapeutic for alpha-1 antitrypsin-related liver disease, demonstrates liver exposure-response and efficacy in preclinical studies Presentation Reference: PS-147 Session: Parallel session: Clinical developments in metabolic and rare disease Date and Time: April 14, 2018 at 9:15 a.m. CET Authors: Christine Wooddell, et al. Poster Presentation: RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naïve, HBeAg positive and negative patients with chronic HBV Presentation Reference: FRI-362 Session: Viral hepatitis B/D: Therapy Session Date and Time: April 13, 2018 from 9 a.m. to 5 p.m. CET Authors: Man-Fung Yuen, et al.
Mar 29, 2018	American Society for Clinical Pharmacology & Therapeutics 2018 Annual Meeting Supporting Materials: American Society for Clinical Pharmacology & Therapeutics 2018 Annual Meeting 1.3 MB
Mar 22, 2018	American Society for Clinical Pharmacology & Therapeutics 2018 Annual Meeting Supporting Materials: American Society for Clinical Pharmacology & Therapeutics 2018 Annual Meeting 1.3 MB
Mar 13, 2018 1:35 PM EDT	Barclays Global Healthcare Conference 2018 Listen to webcast Location: Miami